- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech High Insider Buying
Indian Pharmaceuticals & Biotech High Insider Buying
Results
4
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
4 companies
Alembic Pharmaceuticals
Market Cap: ₹195.8b
Develops, manufactures, and markets pharmaceutical products in India and internationally.
APLLTD
₹996.00
7D
0.7%
1Y
8.6%
Accent Microcell
Market Cap: ₹5.1b
Manufactures, sells, and trades in cellulose-based excipients for the pharmaceutical industry in India and internationally.
ACCENTMIC
₹240.90
7D
-4.1%
1Y
-13.1%
Trident Lifeline
Market Cap: ₹3.3b
A pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally.
543616
₹287.95
7D
2.8%
1Y
77.7%
Smruthi Organics
Market Cap: ₹1.5b
Engages in manufactures and markets active pharmaceutical ingredient (API) products to India, Asia, Africa, the Americas, and Internationally.
540686
₹130.90
7D
-4.5%
1Y
-22.0%